TickerFactsScreenerDevelopers

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $1.66M2013: $475.0K2014: $44.4K2015: $25.3K2016: $199.9K2017: $1.31M2018: $4.27M2019: $2.60M2020: $5.07M2021: $4.82M2022: $5.35M2023: $4.20M$4.20M
2012Cash & Equivalents (USD)2023
Fiscal YearCash & EquivalentsChange YoY
2023$4.20M-21.5%
2022$5.35M+11.0%
2021$4.82M-4.8%
2020$5.07M+95.1%
2019$2.60M-39.2%
2018$4.27M+227.2%
2017$1.31M+553.1%
2016$199.9K+690.8%
2015$25.3K-43.1%
2014$44.4K-90.7%
2013$475.0K-71.3%
2012$1.66M—